机构

• 上海药物研究所 [7]

采集方式

• OAI收割 [7]

内容类型

• 期刊论文 [7]

发表日期

• 2022 [7]

学科主题

筛选

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 发表日期：2022    专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序题名升序题名降序作者升序作者降序发表日期升序发表日期降序 Structure-Based Design of Tropane Derivatives as a Novel Series of CCR5 Antagonists with Broad-Spectrum Anti-HIV-1 Activities and Improved Oral Bioavailability 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 65, 期号: 24, 页码: 16526-16540 作者:  Xie, Xiong;  Zheng, Yu-Gui;  Chen, Huan;  Li, Jian;  Luo, Rong-Hua   |  收藏  |  浏览/下载：26/0  |  提交时间：2023/04/10 Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities 期刊论文  OAI收割 JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 卷号: 10, 期号: 7, 页码: 14 作者:     |  收藏  |  浏览/下载：37/0  |  提交时间：2022/08/30 tumor microenvironment  cytotoxicity  immunologic  drug therapy  combination   Copy Number Analyses Identified a Novel Gene: APOBEC3A Related to Lipid Metabolism in the Pathogenesis of Preeclampsia 期刊论文  OAI收割 FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 卷号: 9, 页码: 13 作者:  Liu, Nan;  Guo, Yu-Na;  Wang, Xiao-Jin;  Ma, Jue;  He, Yun-Ting   |  收藏  |  浏览/下载：30/0  |  提交时间：2022/08/16 preeclampsia  APOBEC3A  lipid metabolism  copy number variation  genetics   Genome-wide gain-of-function screening identifies EZH2 mediating resistance to PI3K alpha inhibitors in oesophageal squamous cell carcinoma 期刊论文  OAI收割 CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 卷号: 12, 期号: 5, 页码: 17 作者:  Xing, Hui;  Gao, Mengshi;  Wang, Yuxiang;  Zhang, Xu;  Shi, Jiajie   |  收藏  |  浏览/下载：47/0  |  提交时间：2022/08/16 CDKNIA  cell cycle  CRISPR-SAM  CYH33  ESCC  EZH2  PI3K alpha inhibitor  resistance   Characterization of a small-molecule inhibitor targeting NEMO/IKK beta to suppress colorectal cancer growth 期刊论文  OAI收割 SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 卷号: 7, 期号: 1, 页码: 13 作者:  Yu, Zhenlong;  Gao, Jian;  Zhang, Xiaolei;  Peng, Yulin;  Wei, Wenlong   |  收藏  |  浏览/下载：29/0  |  提交时间：2022/06/15 Metabolite profiles and mass balance of fuzuloparib, a novel poly (ADP-ribose) polymerase inhibitor, in subjects with advanced solid cancers 期刊论文  OAI收割 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 页码: 14 作者:  Bian, Yicong;  Meng, Jian;  Ma, Sheng;  Li, Guangze;  Wang, Yuya   |  收藏  |  浏览/下载：79/0  |  提交时间：2022/06/15 fuzuloparib  mass balance  metabolite profiles  PARP  pharmacokinetics   Comprehensive Transcriptome Profiling of NAFLD- and NASH-Induced Skeletal Muscle Dysfunction 期刊论文  OAI收割 FRONTIERS IN ENDOCRINOLOGY, 2022, 卷号: 13, 页码: 14 作者:  Guo, Mingwei;  Xiang, Liping;  Yao, Jing   |  收藏  |  浏览/下载：32/0  |  提交时间：2022/08/30 NAFLD  NASH  quadriceps muscle  lipid deposition  insulin resistance  myokines